CA
NZ
UK
AU
IND
US
●BetaBionics rallied about 8.3% as momentum continued to build behind the diabetes-technology company.
● Precision BioSciences jumped roughly 11%, reigniting interest in one of the more closely watched names in the gene-editing space.
● Haoxi Health Technology surged in mid-August trading, an outsized move for a company whose share count has been repeatedly reshaped this year.
● MiNK Therapeutics climbed roughly 7% in a fresh advance, extending a run of sharp swings that has defined the micro-cap cell-therapy name through August 2026.
● Haemonetics Corporation surged about 16% on Tuesday, August 18, 2026, after disclosing a newSupplyagreement with CSL Plasma.
● Assembly Biosciences rose about 7.1%, putting the clinical-stage antiviral developer back on biotech breakout screens.
● The advance follows aBlowoutsecond-quarter report earlier in August showing record revenue.
Shares of Senseonics Holdings (NYSE American:SENS) surged about 8.2% as bulls returned to the diabetes-technology company behind the long-wear Eversense implantable continuous glucose monitor. The move extended the stock's reputation for sharp swings around its evolving growth story.
Tenon Medical (NASDAQ:TNON) rose sharply in mid-August trading, drawing attention to a micro-cap medical-device company that has strung together several notable developments over the summer. The move came on heavyVolumerelative to the company's small size, though a single, clearly disclosed catalyst for the surge …
Shares of Scribe Therapeutics (NASDAQ:SCTX) surged as traders returned to the recently public gene-editing company, one of the few CRISPR biotechs to complete an initial public offering in 2026. The move comes less than a month after Scribe debuted on theNasdaqGlobal Market, and it …
Please wait processing your request...